ArticleJournal of biophotonics2026
Therapeutic Effect of Photobiomodulation and Single Intratendinous Injection at the Lesion Site of Platelet-Rich Fibrin in Inducted Tendinopathy.
Article in Journal of biophotonics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Tendinopathy is a multifactorial condition characterized by collagen disorganization, inflammation, and impaired tendon function. Photobiomodulation (PBM) and platelet-rich fibrin (PRF) have emerged as therapeutic approaches due to their regenerative potential, although their mechanisms during tendon healing remain unclear. This study compared the effects of PBM and PRF, alone or combined, on experimentally induced calcaneal tendinopathy in rats. A total of 75 animals were divided into five groups: control, injury, PRF, PBM, and PRF + PBM. Treatments began 48 h after injury. Functional performance, nociception, and histological features were evaluated up to 21 days. Combined PRF and PBM promoted superior early functional recovery, enhanced collagen synthesis, and increased angiogenesis, despite greater initial inflammation. PBM alone resulted in gradual recovery with better fiber organization, while PRF accelerated function but sustained inflammation. Combined therapy shows promise for tendon repair, supporting stage-specific treatment strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.